Cytek Biosciences
CTKB
CTKB
157 hedge funds and large institutions have $270M invested in Cytek Biosciences in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 65 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
13% less capital invested
Capital invested by funds: $311M → $270M (-$40.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
157
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$2.75M | |
| 3 | +$2M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.95M |
| 5 |
Millennium Management
New York
|
+$1.43M |
Top Sellers
| 1 | -$6.19M | |
| 2 | -$3.44M | |
| 3 | -$3.39M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.7M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.68M |